1. Home
  2. JXJT vs CVKD Comparison

JXJT vs CVKD Comparison

Compare JXJT & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXJT
  • CVKD
  • Stock Information
  • Founded
  • JXJT 2012
  • CVKD 2022
  • Country
  • JXJT China
  • CVKD United States
  • Employees
  • JXJT N/A
  • CVKD N/A
  • Industry
  • JXJT Apparel
  • CVKD Medicinal Chemicals and Botanical Products
  • Sector
  • JXJT Consumer Staples
  • CVKD Health Care
  • Exchange
  • JXJT Nasdaq
  • CVKD Nasdaq
  • Market Cap
  • JXJT 8.1M
  • CVKD 8.2M
  • IPO Year
  • JXJT 2012
  • CVKD 2023
  • Fundamental
  • Price
  • JXJT $1.34
  • CVKD $0.43
  • Analyst Decision
  • JXJT
  • CVKD Strong Buy
  • Analyst Count
  • JXJT 0
  • CVKD 2
  • Target Price
  • JXJT N/A
  • CVKD $3.50
  • AVG Volume (30 Days)
  • JXJT 663.1K
  • CVKD 71.6K
  • Earning Date
  • JXJT 08-14-2024
  • CVKD 08-12-2024
  • Dividend Yield
  • JXJT N/A
  • CVKD N/A
  • EPS Growth
  • JXJT N/A
  • CVKD N/A
  • EPS
  • JXJT 0.48
  • CVKD N/A
  • Revenue
  • JXJT $31,840,588.00
  • CVKD N/A
  • Revenue This Year
  • JXJT N/A
  • CVKD N/A
  • Revenue Next Year
  • JXJT N/A
  • CVKD N/A
  • P/E Ratio
  • JXJT $2.78
  • CVKD N/A
  • Revenue Growth
  • JXJT N/A
  • CVKD N/A
  • 52 Week Low
  • JXJT $1.04
  • CVKD $0.36
  • 52 Week High
  • JXJT $8.51
  • CVKD $2.17
  • Technical
  • Relative Strength Index (RSI)
  • JXJT 54.99
  • CVKD 40.00
  • Support Level
  • JXJT $1.20
  • CVKD $0.43
  • Resistance Level
  • JXJT $1.33
  • CVKD $0.49
  • Average True Range (ATR)
  • JXJT 0.23
  • CVKD 0.02
  • MACD
  • JXJT -0.00
  • CVKD -0.00
  • Stochastic Oscillator
  • JXJT 26.44
  • CVKD 0.17

About JXJT JX Luxventure Limited

JX Luxventure Ltd is engaged in the business of menswear, cross-border merchandise, airfare, and tourism. The company operates in three segments Tourism products, Technology and Cross- board merchandise. The majority of the group revenue is generated from the Tourism products.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Share on Social Networks: